DoW Lung Cancer Translational Research Award

DOD-AMRAA Posted HT942526LCRPTRA

Description

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.
Funding Details
Award Floor
Not specified
Award Ceiling
Not specified
Total Estimated Funding
$9,100,000.00
Expected Awards
6
Key Dates
Posted
May 5, 2026
Closes
September 2, 2026 31d
Archive Date
October 2, 2026
Agency Information
Agency Name
Defense Health Agency Contracting Activity - DHACA
Agency Code
DOD-AMRAA
Funding Instrument
Other